These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 24249810)
1. FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Bocelli-Tyndall C; Trella E; Frachet A; Zajac P; Pfaff D; Geurts J; Heiler S; Barbero A; Mumme M; Resink TJ; Schaeren S; Spagnoli GC; Tyndall A Ann Rheum Dis; 2015 Jan; 74(1):260-6. PubMed ID: 24249810 [TBL] [Abstract][Full Text] [Related]
2. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells. Wang Z; Ding L; Zhang S; Jiang T; Yang Y; Li R Int J Mol Med; 2014 Dec; 34(6):1720-6. PubMed ID: 25270538 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Bocelli-Tyndall C; Zajac P; Di Maggio N; Trella E; Benvenuto F; Iezzi G; Scherberich A; Barbero A; Schaeren S; Pistoia V; Spagnoli G; Vukcevic M; Martin I; Tyndall A Arthritis Rheum; 2010 Dec; 62(12):3815-25. PubMed ID: 20824797 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. Tsubaki M; Satou T; Itoh T; Imano M; Yanae M; Kato C; Takagoshi R; Komai M; Nishida S Mol Cell Endocrinol; 2012 Sep; 361(1-2):219-31. PubMed ID: 22579611 [TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H; Guo J; Bringhurst FR J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438 [TBL] [Abstract][Full Text] [Related]
6. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption. Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542 [TBL] [Abstract][Full Text] [Related]
7. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. Shin HH; Kim SJ; Kang SY; Lee DS; Choi HS Bone; 2006 Oct; 39(4):716-23. PubMed ID: 16750437 [TBL] [Abstract][Full Text] [Related]
8. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492 [TBL] [Abstract][Full Text] [Related]
9. The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate. Fernández M; Pino AM; Figueroa P; Rodríguez JP J Cell Biochem; 2010 Sep; 111(1):130-7. PubMed ID: 20506157 [TBL] [Abstract][Full Text] [Related]
10. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. Ikeda T; Utsuyama M; Hirokawa K J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864 [TBL] [Abstract][Full Text] [Related]
11. Effect of bFGF on HLA-DR expression of human bone marrow-derived mesenchymal stem cells. Dighe PA; Viswanathan P; Mruthunjaya AK; Seetharam RN J Stem Cells; 2013; 8(1):43-57. PubMed ID: 24459812 [TBL] [Abstract][Full Text] [Related]
12. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459 [TBL] [Abstract][Full Text] [Related]
13. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression. Brechter AB; Lerner UH Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065 [TBL] [Abstract][Full Text] [Related]
14. Effects of Enterococcus faecalis lipoteichoic acid on receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in periodontal ligament fibroblasts. Zhao L; Chen J; Cheng L; Wang X; Du J; Wang F; Peng Z Int Endod J; 2014 Feb; 47(2):163-72. PubMed ID: 23710898 [TBL] [Abstract][Full Text] [Related]
15. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178 [TBL] [Abstract][Full Text] [Related]
16. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604 [TBL] [Abstract][Full Text] [Related]
17. Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation. Liao C; Hua Y Arch Oral Biol; 2013 Dec; 58(12):1784-90. PubMed ID: 24200305 [TBL] [Abstract][Full Text] [Related]
18. Effects of Wenyangbushen formula on the expression of VEGF, OPG, RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis. Song HM; Wei YC; Li N; Wu B; Xie N; Zhang KM; Wang SZ; Wang HM Mol Med Rep; 2015 Dec; 12(6):8155-61. PubMed ID: 26496816 [TBL] [Abstract][Full Text] [Related]
19. [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients]. Wang J; Gao H; Wang K; Li W; Shi Z; Zhang M Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jul; 23(7):777-80. PubMed ID: 19662974 [TBL] [Abstract][Full Text] [Related]
20. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]